(Q54514341)

English

Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant. (English)

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

autoimmune myocarditis

1 reference

based on heuristic

inferred from title

author name string

Somasundaram Arumugam

1

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Rajarajan A Thandavarayan

2

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Punniyakoti T Veeraveedu

3

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Vijayasree V Giridharan

4

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Vivian Soetikno

5

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Meilei Harima

6

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Kenji Suzuki

7

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Masaki Nagata

8

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Ritsuo Tagaki

9

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Makoto Kodama

10

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Kenichi Watanabe

11

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

publication date

18 April 2012

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

93

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

2

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

183-189

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Diagnosis of myocarditis: death of Dallas criteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Role of AMP-activated protein kinase in healthy and diseased hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3β signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Protein Kinase Cα Negatively Regulates Systolic and Diastolic Function in Pathological Hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Palmitate-mediated Alterations in the Fatty Acid Metabolism of Rat Neonatal Cardiac Myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Rat dilated cardiomyopathy after autoimmune giant cell myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Control of muscle development by dueling HATs and HDACs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Protein kinase C activation and its pharmacological inhibition in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Optimization of cardiac metabolism in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Molecular targets and regulators of cardiac hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Clinical usefulness of edaravone for acute liver injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Alterations in energy metabolism in cardiomyopathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Comparative effects of torasemide and furosemide in rats with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

The protein kinase C isoforms leading to MAP-kinase activation in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.04.012

7 January 2021

Identifiers

10.1016/J.YEXMP.2012.04.012

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22542793

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54514341&oldid=1532521149"